Affiliation:
1. First Hospital of Shanxi Medical University
Abstract
Abstract
Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. Our research team previously used high-throughput sequencing to reveal the significant differences of serum exosomal miR-133a-3p, miR-206, and miR-549a-3p were significantly different from the control group in the severe TBI (sTBI), mild or moderate TBI (mTBI), and control groups. However, there is a lack of convincing experimental evidence. To address this, the present study experimentally sought to verify Our current study verifies the potential of serum exosomes miR-206 and miR-549a-3p as potential biomarkers in TBI patients and their association with inflammatory response and oxidative stress through real-time fluorescence quantification, enzyme-linked immunosorbent assay, and statistical analysis.
Publisher
Research Square Platform LLC